Back to Search
Start Over
Additional information on "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET".
- Source :
-
European Journal of Nuclear Medicine & Molecular Imaging . Feb2020, Vol. 47 Issue 2, p505-506. 2p. - Publication Year :
- 2020
-
Abstract
- In DFO*, the trihydroxamate DFO is elongated with an extra hydroxamate group, exactly the same as present in DFO. Initially the in vivo stability of [ SP 89 sp Zr]Zr-DFOcyclo*-trastuzumab was compared with [ SP 89 sp Zr]Zr-DFO-trastuzumab, of which the results are depicted in Fig. [Extracted from the article]
- Subjects :
- *CYCLIC groups
*TUMOR growth
Subjects
Details
- Language :
- English
- ISSN :
- 16197070
- Volume :
- 47
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- European Journal of Nuclear Medicine & Molecular Imaging
- Publication Type :
- Academic Journal
- Accession number :
- 141318834
- Full Text :
- https://doi.org/10.1007/s00259-019-04561-8